Effectiveness of Electroacupuncture or Auricular Acupuncture vs Usual Care for Chronic Musculoskeletal Pain Among Cancer Survivors: The PEACE Randomized Clinical Trial

Mao et al. · JAMA Oncology · 2021

🎯Randomized Controlled Trial👥n=360 participantsHigh impact - JAMA Oncology

Evidence Level

STRONG
85/ 100
Quality
5/5
Sample
4/5
Replication
4/5
🎯

OBJECTIVE

To compare the effectiveness of electroacupuncture and auriculotherapy versus usual care for chronic musculoskeletal pain in cancer survivors

👥

WHO

360 cancer survivors with chronic musculoskeletal pain for at least 3 months

⏱️

DURATION

12 weeks of treatment with follow-up to 24 weeks

📍

POINTS

Electroacupuncture: 4 local points + 4 systemic; Auriculotherapy: cingulate, thalamus, omega 2, zero point, shen men

🔬 Study Design

360participants
randomization

Electroacupuncture

n=145

10 weekly sessions of electroacupuncture

Auriculotherapy

n=143

10 weekly sessions of auriculotherapy (battlefield acupuncture)

Usual care

n=72

Standard pain treatment

⏱️ Duration: 12 weeks

📊 Results in numbers

1.9 points

Pain reduction - Electroacupuncture

1.6 points

Pain reduction - Auriculotherapy

0%

Dropout rate - Electroacupuncture

0%

Dropout rate - Auriculotherapy

Percentage highlights

0.7%
Dropout rate - Electroacupuncture
10.5%
Dropout rate - Auriculotherapy

📊 Outcome Comparison

Reduction in BPI pain scale (0-10)

Electroacupuncture
1.9
Auriculotherapy
1.6
Usual care
0.48
💬 What does this mean for you?

This study showed that both electroacupuncture and auriculotherapy are more effective than conventional treatment for reducing chronic pain in cancer survivors. Electroacupuncture was slightly more effective and better tolerated, but both techniques provided significant pain relief that persisted for months after treatment.

📝

Article summary

Plain-language narrative summary

Chronic pain represents one of the greatest challenges faced by cancer survivors, affecting approximately half of this growing population worldwide. Unlike the general population, these patients carry an additional burden of suffering related to prior cancer treatments, such as surgeries, chemotherapy, radiation therapy, and hormonal therapies, which can leave lasting painful sequelae. Inadequately treated pain significantly compromises quality of life, impairs physical function, and may even negatively influence cancer-related outcomes. With the current opioid crisis in the United States, it has become even more urgent to find effective non-pharmacological alternatives for pain management, especially considering that nearly half of cancer survivors do not receive adequate treatment for their painful symptoms.

The PEACE (Personalized Electroacupuncture vs Auricular Acupuncture Comparative Effectiveness) study was conducted to evaluate the effectiveness of two acupuncture techniques in the treatment of chronic musculoskeletal pain in cancer survivors. This randomized clinical trial involved 360 adults who had been treated for cancer but had no current evidence of disease, all suffering from musculoskeletal pain for at least three months. The study was conducted between March 2017 and October 2019, distributed between the urban center of Memorial Sloan Kettering Cancer Center and five suburban sites in New York and New Jersey. Participants were randomly divided into three groups: electroacupuncture (145 patients), auricular acupuncture (143 patients), and usual care (72 patients).

The acupuncture groups received ten weekly sessions of treatment, while the usual care group continued with the standard treatment prescribed by their physicians, including analgesic medications, physical therapy, and injections when necessary.

The results demonstrated significant benefits for both acupuncture techniques. In electroacupuncture, licensed acupuncturists selected specific points near the painful area and additional points in other parts of the body, applying electrical stimulation at some points for 30 minutes. Auricular acupuncture followed a standardized military protocol known as "battlefield acupuncture," focusing exclusively on specific points on the ears, with shorter sessions of 10 to 20 minutes. After 12 weeks of treatment, both techniques produced clinically significant reductions in pain intensity compared to usual care.

Electroacupuncture reduced pain scores by 1.9 points on a 0-10 scale, while auricular acupuncture reduced 1.6 points. To put these numbers in context, a 1-point reduction on this scale is considered clinically relevant by experts. In addition to pain improvement, both treatments also resulted in better quality of life, greater functional capacity, and reduced use of analgesic medications.

For patients and healthcare professionals, these findings offer promising perspectives in the management of chronic pain in cancer survivors. Electroacupuncture proved to be particularly effective and well tolerated, with only one patient discontinuing treatment due to mild adverse effects, mainly bruising at needle sites. Auricular acupuncture, although also effective, had a higher discontinuation rate, with 15 patients discontinuing treatment due primarily to ear pain. Importantly, the benefits of both techniques persisted up to 24 weeks after treatment initiation, suggesting long-lasting effects.

These results are especially relevant considering that Medicare in the United States recently began covering acupuncture for chronic low back pain, and studies like this strengthen the argument for expanding this coverage to other types of chronic pain in cancer survivors.

The study has some important limitations that should be considered. First, it was not possible to apply a true placebo control, since both patients and acupuncturists knew which treatment was being applied, which may introduce some bias into the results. Second, the treatments were applied by experienced and licensed acupuncturists, so the effects may differ if auricular acupuncture is applied by professionals without specific training in acupuncture, as is being implemented in the U.S. military system.

Third, the study was conducted at an academic cancer center with urban and suburban locations, with additional research needed in community settings, especially in rural and underserved areas, to determine whether the results can be generalized. Despite these limitations, this study represents a significant contribution to the arsenal of non-pharmacological options in the treatment of chronic pain, offering cancer survivors safe and effective alternatives that can substantially improve their quality of life without the risks associated with prolonged opioid use.

Strengths

  • 1Large, well-designed study with 360 diverse participants
  • 2Direct comparison between two acupuncture techniques
  • 3Long-lasting effects maintained up to 24 weeks
  • 4Improvement also in quality of life and reduction in medication use
  • 5Diverse population including different cancer types
⚠️

Limitations

  • 1Absence of sham acupuncture control group
  • 2Inability to blind patients and therapists
  • 3Conducted only in urban and suburban academic centers
  • 4Auriculotherapy had higher rates of adverse events and dropout
  • 5Did not test combination of the two techniques
Prof. Dr. Hong Jin Pai

Expert Commentary

Prof. Dr. Hong Jin Pai

PhD in Sciences, University of São Paulo

Clinical Relevance

Chronic musculoskeletal pain in cancer survivors constitutes a clinical problem of growing scale that is systematically underestimated in oncology and pain medicine clinics. The PEACE trial answers a concrete question: among the available non-pharmacological options, does acupuncture have comparable or superior effectiveness to conventional treatment in this specific population? With 360 participants distributed across three arms and follow-up to 24 weeks, the answer is affirmative for electroacupuncture and auriculotherapy, both outperforming usual care in pain reduction, functional capacity, and quality of life, with concomitant reduction in analgesic use. This positions electroacupuncture, in particular, as a first-line option in the integrative planning for survivors who carry painful sequelae from chemotherapy, radiation therapy, or hormonal therapy — a population that frequently does not tolerate opioids and deserves a structured, evidence-based approach.

Notable Findings

Two findings deserve special attention. The first is the magnitude of pain reduction with electroacupuncture — 1.9 points on the numeric scale — which exceeds the minimal clinically important difference threshold established in the chronic pain literature and was sustained through week 24, that is, 12 weeks after the end of sessions. This carryover effect suggests durable neuroplastic modulation, not just transient symptomatic suppression. The second finding is the dramatic contrast in dropout rates: 0.7% in electroacupuncture versus 10.5% in auriculotherapy. This difference has direct implication in the technical choice in clinical practice — auriculotherapy by the battlefield protocol, although effective, generated ear pain that compromised adherence. In oncohematologic populations with multiple comorbidities and lower tolerance to discomfort, electroacupuncture emerges as the more robust modality in terms of adherence and outcome.

From My Experience

At the Pain Center of HC-FMUSP, we have been seeing cancer survivors with musculoskeletal pain for many years, and the pattern I observe is consistent with the PEACE findings: electroacupuncture usually produces perceptible response between the third and fifth sessions, with more evident functional gain from the seventh or eighth session onward. I usually work with cycles of ten weekly sessions, followed by monthly maintenance for six to twelve months depending on the etiology — neuropathy from platinums or taxanes requires longer maintenance than arthralgia from aromatase inhibitors. I systematically combine this with supervised aerobic exercise and, when there is a pronounced central component, duloxetine or pregabalin at adjuvant doses. I reserve auriculotherapy as a complement or for patients with technical restrictions to body electroacupuncture, not as a first-line substitute. Patients with concomitant fibromyalgia or central sensitization syndromes respond more slowly and deserve calibrated expectations from the outset.

Specialist physician in Medical Acupuncture. Adjunct Professor at the Institute of Orthopedics, HC-FMUSP. Coordinator of the Acupuncture Group at the HC-FMUSP Pain Center.

Full original article

Read the full scientific study

JAMA Oncology · 2021

DOI: 10.1001/jamaoncol.2021.0310

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.